1. Hirt R, Berchtold R: Biophysical studies with synthetic lecithin as a road to new chemotherapeutic agents. Cancer Chemotherap Rep 18:5–7, 1962.
2. Burchenal JH, Lyman MS, Purple JR, Coley V, Smith S, Bucholz E: Therapeutic combination and resistant studies on certain imidazolin phthalanilide derivatives in mouse leukemia. Cancer Chemotherap Rep 19:19–29, 1962.
3. Pittillo RF, Bennett LL, Jr, Short WA, Tomisek AJ, Dixon GJ, Thomson JR, Laster WR, Jr, Trader M, Mattil L, Allan P, Bowdon B, Schabel FM, Jr, Skipper HE: Preliminary studies of some terephthalanilides — A new class of antitumor drugs. Cancer Chemotherap Rep 19:41–53, 1962.
4. Schepartz SA, Wodinsky I, Leiter J: Phthalanilides — A new group of potential antitumor agents. Cancer chemotherap Rep 19:1–3, 1962.
5. Venditti JM, Goldin A, Kline I: Studies on the effectiveness of 4′, 4′′-Di (2.Imidazolin-2-yl) terephthalanilides against mouse leukemia L1210 and resistant variants. Cancer Chemotherap Rep 19:5–11, 1962.